Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):655-6. doi: 10.1097/00126334-200308150-00019.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HTLV-II Infections / complications*
  • HTLV-II Infections / drug therapy*
  • Human T-lymphotropic virus 2 / isolation & purification*
  • Humans
  • Middle Aged
  • Proviruses / isolation & purification*
  • Viral Load

Substances

  • Anti-HIV Agents